BRPI0719869A2 - Composto ou um sal do mesmo, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em uma mamífero, e, uso do composto. - Google Patents
Composto ou um sal do mesmo, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em uma mamífero, e, uso do composto.Info
- Publication number
- BRPI0719869A2 BRPI0719869A2 BRPI0719869-8A2A BRPI0719869A BRPI0719869A2 BR PI0719869 A2 BRPI0719869 A2 BR PI0719869A2 BR PI0719869 A BRPI0719869 A BR PI0719869A BR PI0719869 A2 BRPI0719869 A2 BR PI0719869A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituent
- compound
- optionally
- salt
- mammalian
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006332647 | 2006-12-08 | ||
| PCT/JP2007/073680 WO2008069311A1 (ja) | 2006-12-08 | 2007-12-07 | 三環性化合物およびその医薬用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0719869A2 true BRPI0719869A2 (pt) | 2014-04-15 |
Family
ID=39492186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719869-8A2A BRPI0719869A2 (pt) | 2006-12-08 | 2007-12-07 | Composto ou um sal do mesmo, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em uma mamífero, e, uso do composto. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8273761B2 (pt) |
| EP (1) | EP2100895B1 (pt) |
| JP (1) | JP5227806B2 (pt) |
| KR (1) | KR20090086641A (pt) |
| CN (1) | CN101605795A (pt) |
| AT (1) | ATE548371T1 (pt) |
| AU (1) | AU2007329879A1 (pt) |
| BR (1) | BRPI0719869A2 (pt) |
| CA (1) | CA2671354A1 (pt) |
| EA (1) | EA200970555A1 (pt) |
| MX (1) | MX2009006078A (pt) |
| WO (1) | WO2008069311A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101622233A (zh) | 2006-12-28 | 2010-01-06 | 武田药品工业株式会社 | 三环化合物及其药物用途 |
| EP2884275A4 (en) * | 2012-07-10 | 2016-04-13 | Astellas Pharma Inc | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF STRESS-RELATED HARNINE CONTINENCE OR MIXED INCONTINENCE AND METHOD FOR SCREENING COMPOUNDS FOR INTRODUCTION TO THIS PHARMACEUTICAL COMPOSITION |
| AR091699A1 (es) * | 2012-07-10 | 2015-02-25 | Astellas Pharma Inc | Derivado de indol carboxamida |
| EP3322292A4 (en) * | 2015-06-12 | 2019-01-09 | Mayo Foundation For Medical Education And Research | MUMPSVIRUS AS POTENTIAL ONCOLYTIC MEDIUM |
| KR20180100646A (ko) | 2016-01-08 | 2018-09-11 | 다케다 야쿠힌 고교 가부시키가이샤 | 자폐 스펙트럼 장애의 예방 또는 치료제 |
| WO2017119456A1 (ja) | 2016-01-08 | 2017-07-13 | 武田薬品工業株式会社 | せん妄の予防または治療剤 |
| SG11202006906XA (en) | 2018-03-09 | 2020-09-29 | Recurium Ip Holdings Llc | Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326192D0 (en) | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| FR2725985B1 (fr) * | 1994-10-21 | 1996-11-15 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5998461A (en) * | 1994-10-21 | 1999-12-07 | Adir Et Compagnie | Tricyclic amide compounds |
| FR2732969B1 (fr) * | 1995-04-14 | 1997-05-16 | Adir | Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| PL188093B1 (pl) | 1996-03-08 | 2004-12-31 | Takeda Chemical Industries Ltd | Związek trójpierścieniowy, sposób jego wytwarzania i zastosowanie, kompozycja farmaceutyczna oraz związki pośrednie |
| JP2006528685A (ja) | 2003-05-06 | 2006-12-21 | スミスクライン ビーチャム コーポレーション | 新規化合物 |
| WO2006027424A1 (fr) * | 2004-08-12 | 2006-03-16 | Inria Institut National De Recherche En Informatique Et En Automatique | Dispositif de contrôle de communications |
| FR2874611B1 (fr) * | 2004-08-31 | 2006-11-17 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| ATE381250T1 (de) | 2005-05-13 | 2007-12-15 | Sefar Ag | Leiterplatte und verfahren zu deren herstellung |
-
2007
- 2007-12-07 US US12/448,094 patent/US8273761B2/en not_active Expired - Fee Related
- 2007-12-07 BR BRPI0719869-8A2A patent/BRPI0719869A2/pt not_active IP Right Cessation
- 2007-12-07 KR KR1020097014200A patent/KR20090086641A/ko not_active Application Discontinuation
- 2007-12-07 JP JP2008548352A patent/JP5227806B2/ja not_active Expired - Fee Related
- 2007-12-07 CA CA002671354A patent/CA2671354A1/en not_active Abandoned
- 2007-12-07 CN CNA2007800511626A patent/CN101605795A/zh active Pending
- 2007-12-07 EA EA200970555A patent/EA200970555A1/ru unknown
- 2007-12-07 EP EP07850267A patent/EP2100895B1/en not_active Not-in-force
- 2007-12-07 AU AU2007329879A patent/AU2007329879A1/en not_active Abandoned
- 2007-12-07 AT AT07850267T patent/ATE548371T1/de active
- 2007-12-07 WO PCT/JP2007/073680 patent/WO2008069311A1/ja active Application Filing
- 2007-12-07 MX MX2009006078A patent/MX2009006078A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101605795A (zh) | 2009-12-16 |
| MX2009006078A (es) | 2009-09-18 |
| KR20090086641A (ko) | 2009-08-13 |
| JP5227806B2 (ja) | 2013-07-03 |
| EP2100895A1 (en) | 2009-09-16 |
| JPWO2008069311A1 (ja) | 2010-03-25 |
| WO2008069311A1 (ja) | 2008-06-12 |
| US20100029707A1 (en) | 2010-02-04 |
| EA200970555A1 (ru) | 2010-02-26 |
| CA2671354A1 (en) | 2008-06-12 |
| EP2100895A4 (en) | 2009-12-23 |
| ATE548371T1 (de) | 2012-03-15 |
| EP2100895B1 (en) | 2012-03-07 |
| AU2007329879A1 (en) | 2008-06-12 |
| US8273761B2 (en) | 2012-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1891029T3 (pl) | Związki organiczne do leczenia stanów zapalnych lub alergicznych | |
| BRPI0719869A2 (pt) | Composto ou um sal do mesmo, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em uma mamífero, e, uso do composto. | |
| BRPI0607433A2 (pt) | composto ou um sal do mesmo, pró-droga, agente farmacêutico, inibidor de peptidase, uso de um composto ou de uma pró-droga do mesmo, e, métodos de prevenção ou tratamento de doenças, de inibição de peptidase em um mamìfero, e de produção de um composto | |
| BRPI0608436A2 (pt) | derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor | |
| NO20081315L (no) | Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| WO2007125321A3 (en) | Purine and deazapurine derivatives as pharmaceutical compounds | |
| BRPI0409198A (pt) | derivados quinolin-2-ona para o tratamento de doenças de vias aéreas | |
| NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
| HK1139931A1 (en) | Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives | |
| TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
| NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
| BRPI0708038B8 (pt) | derivado de cumarina, composição farmacêutica e agente terapêutico para um distúrbio proliferativo celular | |
| TW200726753A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
| MY141024A (en) | Niacin receptor agonists, compositions containing such compounds and methods of treatment | |
| ATE457988T1 (de) | A2a-adenosin-rezeptor-antagonisten | |
| NO20082496L (no) | Pyrazinderivater | |
| TW200639159A (en) | Treatment of pain | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
| MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
| DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A, 5A E 6A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |